calanolide a has been researched along with costatolide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulanger, WA; Chen, W; Cibulski, M; Flavin, MT; Flavin, TM; Greenwood, EM; Hughes, SH; Khilevich, A; Kucherenko, A; Lin, L; Pengsuparp, T; Pezzuto, JM; Rizzo, JD; Sheinkman, AK; Shone, RL; Vilaychack, V; Xu, ZQ | 1 |
| Hughes, SH; Pengsuparp, T; Pezzuto, JM; Serit, M; Soejarto, DD | 1 |
| Boyd, MR; Cardellina, JH; Fuller, RW; Galinis, DL; Gulakowski, RJ; McKee, TC; McMahon, JB | 1 |
| Bader, JP; Cragg, GM; Newman, DJ; Yang, SS | 1 |
1 review(s) available for calanolide a and costatolide
| Article | Year |
|---|---|
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
Topics: Amino Acid Sequence; Anti-HIV Agents; HIV-1; Models, Biological; Models, Chemical; Molecular Sequence Data; National Institutes of Health (U.S.); Retrospective Studies; United States; Virus Replication | 2001 |
3 other study(ies) available for calanolide a and costatolide
| Article | Year |
|---|---|
Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Coumarins; HIV; HIV Reverse Transcriptase; Nucleic Acid Synthesis Inhibitors; Pyranocoumarins; RNA-Directed DNA Polymerase; Stereoisomerism | 1996 |
Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of calophyllum teysmannii.
Topics: Coumarins; DNA-Directed RNA Polymerases; HIV Reverse Transcriptase; HIV-1; Humans; Indicators and Reagents; Latex; Nucleic Acid Synthesis Inhibitors; Plants, Medicinal; Reverse Transcriptase Inhibitors; Ribonuclease H | 1996 |
Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.
Topics: Anti-HIV Agents; Antiviral Agents; Coumarins; Cytopathogenic Effect, Viral; Humans; Pyranocoumarins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |